Display options
Cite
Farooq AV, Soin K, Moss HE. Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies. Neuroophthalmology. 2015;39(3):140-143doi: 10.3109/01658107.2015.1011755.
Farooq, A. V., Soin, K., & Moss, H. E. (2015). Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies. Neuro-ophthalmology (Aeolus Press), 39(3), 140-143. https://doi.org/10.3109/01658107.2015.1011755
Farooq, Asim V, et al. "Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies." Neuro-ophthalmology (Aeolus Press) vol. 39,3 (2015): 140-143. doi: https://doi.org/10.3109/01658107.2015.1011755
Farooq AV, Soin K, Moss HE. Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies. Neuroophthalmology. 2015;39(3):140-143. doi: 10.3109/01658107.2015.1011755. Epub 2015 May 13. PMID: 26594078; PMCID: PMC4460821.
Copy Download .nbib Format: NLM
Share it on

Neuroophthalmology. 2015;39(3):140-143. doi: 10.3109/01658107.2015.1011755. Epub 2015 May 13.

Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies.

Neuro-ophthalmology (Aeolus Press)

Asim V Farooq, Ketki Soin, Heather E Moss

Affiliations

  1. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL.

PMID: 26594078 PMCID: PMC4460821 DOI: 10.3109/01658107.2015.1011755

Abstract

The presence of an elevated anti-glutamic acid decarboxylase (GAD) antibody level has been associated with a number of eye movement abnormalities, as well as other findings including cerebellar ataxia and insulin dependent diabetes mellitus. Skew deviation in association with anti-GAD antibodies has not been previously reported. Here we report a case of alternating skew deviation along with cerebellar-brainstem signs in a patient with an elevated anti-GAD antibody titer. Follow-up neurologic evaluation after treatment with intravenous immunoglobulin revealed improvement in cerebellar-brainstem signs, while ophthalmic evaluation was stable.

References

  1. J Neurol. 2013 Oct;260(10):2675-7 - PubMed
  2. J Neurol. 2005 May;252 Suppl 1:I19-25 - PubMed
  3. Arch Neurol. 2005 Aug;62(8):1300-3 - PubMed
  4. Arch Neurol. 2001 Feb;58(2):225-30 - PubMed
  5. Expert Rev Clin Immunol. 2013 Nov;9(11):1043-53 - PubMed
  6. Ann N Y Acad Sci. 2005 Apr;1039:446-54 - PubMed
  7. Neurology. 2006 Sep 26;67(6):1068-70 - PubMed
  8. Ann Neurol. 1988 Feb;23(2):190-2 - PubMed
  9. Neurol Sci. 2002 Oct;23(4):145-51 - PubMed
  10. Case Rep Med. 2014;2014:545490 - PubMed
  11. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):998-9 - PubMed
  12. Eur J Neurol. 2010 Jan;17(1):e5 - PubMed
  13. Dev Med Child Neurol. 1999 Jul;41(7):489-90 - PubMed
  14. Diabetes Metab. 2008 Sep;34(4 Pt 1):386-8 - PubMed
  15. Clin Neurol Neurosurg. 2008 Jun;110(6):619-21 - PubMed
  16. Brain. 2008 Oct;131(Pt 10):2553-63 - PubMed

Publication Types

Grant support